Showing results (1-10 of 370) with videos related to
Sort By:
Pageof 37
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2020
Reinfection With SARS-CoV-2: Implications for VaccinesJeffrey I Cohen, Peter D BurbeloVirology|July 9, 2009
Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assayJunji Sashihara, Peter D Burbelo, Barbara Savoldo, et al.Clinical and Vaccine Immunology : CVI|April 16, 2010
Rapid, simple, quantitative, and highly sensitive antibody detection for lyme diseasePeter D Burbelo, Alexandra T Issa, Kathryn H Ching, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 4, 2014
A seroprevalence study of primate workers for asymptomatic rhesus cytomegalovirus infectionJ Jason Bowman, Peter D Burbelo, Rachel B Gill, et al.Clinical and Vaccine Immunology : CVI|January 9, 2009
Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assayPeter D Burbelo, Yo Hoshino, Hannah Leahy, et al.Clinical and Vaccine Immunology : CVI|July 4, 2014
Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assayJeffrey I Cohen, Mir A Ali, Ahmad Bayat, et al.The Journal of Infectious Diseases|August 26, 2009
Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigsYo Hoshino, Lesley Pesnicak, Kennichi C Dowdell, et al.Plos Pathogens|October 27, 2011
Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challengeJunji Sashihara, Yo Hoshino, J Jason Bowman, et al.Pediatric Hematology and Oncology|February 9, 2022
Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucelOren M Gordon, Madeline Terpilowski, Robin Dulman, et al.Journal of Medical Virology|October 25, 2023
Characterization of B-cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS-CoV-2 infectionEvgeny Arons, Kiersten Henry, Christopher Haas, et al.Pageof 37